Crystal Rock Capital Management Boston Scientific Corp Transaction History
Crystal Rock Capital Management
- $163 Million
- Q2 2024
A detailed history of Crystal Rock Capital Management transactions in Boston Scientific Corp stock. As of the latest transaction made, Crystal Rock Capital Management holds 94,875 shares of BSX stock, worth $7.97 Million. This represents 4.47% of its overall portfolio holdings.
Number of Shares
94,875
Previous 94,875
-0.0%
Holding current value
$7.97 Million
Previous $6.5 Million
12.45%
% of portfolio
4.47%
Previous 3.9%
Shares
10 transactions
Others Institutions Holding BSX
# of Institutions
1,472Shares Held
1.21BCall Options Held
8.13MPut Options Held
8.41M-
Vanguard Group Inc Valley Forge, PA130MShares$10.9 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$10.6 Billion0.22% of portfolio
-
State Street Corp Boston, MA61.5MShares$5.16 Billion0.21% of portfolio
-
Primecap Management CO Pasadena, CA38MShares$3.19 Billion2.15% of portfolio
-
Wellington Management Group LLP Boston, MA32.1MShares$2.7 Billion0.45% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $120B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...